| Copper | Approved Investigational | GADD45A | 1647 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GADD45A mRNA | 1p31.3 | |
| Copper | Approved Investigational | GADD45B | 4616 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GADD45B mRNA | 19p13.3 | |
| Copper | Approved Investigational | GADD45B | 4616 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GADD45B mRNA | 19p13.3 | |
| Copper | Approved Investigational | GADD45G | 10912 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GADD45G mRNA | 9q22.2 | |
| Copper | Approved Investigational | GAL | 51083 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GAL mRNA | 11q13.2 | |
| Copper | Approved Investigational | GALK1 | 2584 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GALK1 mRNA | 17q25.1 | |
| Copper | Approved Investigational | GALNT10 | 55568 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GALNT10 mRNA | 5q33.2 | |
| Copper | Approved Investigational | GALNT18 | 374378 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GALNT18 mRNA | 11p15.4 | |
| Copper | Approved Investigational | GAMT | 2593 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GAMT mRNA | 19p13.3 | |
| Copper | Approved Investigational | GAS2L1 | 10634 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GAS2L1 mRNA | 22q12.2 | |
| Copper | Approved Investigational | GAS5 | 60674 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GAS5 mRNA | 1q25.1 | |
| Copper | Approved Investigational | GAS6 | 2621 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GAS6 mRNA | 13q34 | |
| Copper | Approved Investigational | GAST | 2520 |
upregulated | Copper results in increased expression of GAST mRNA | 17q21.2 | |
| Copper | Approved Investigational | GATA2 | 2624 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GATA2 mRNA | 3q21.3 | |
| Copper | Approved Investigational | GBE1 | 2632 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GBE1 mRNA | 3p12.2 | |
| Copper | Approved Investigational | GBP4 | 115361 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of GBP4 mRNA | 1p22.2 | |
| Copper | Approved Investigational | GCAT | 23464 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GCAT mRNA | 22q13.1 | |
| Copper | Approved Investigational | GCC1 | 79571 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GCC1 mRNA | 7q32.1 | |
| Copper | Approved Investigational | GCDH | 2639 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GCDH mRNA | 19p13.13 | |
| Copper | Approved Investigational | GCGR | 2642 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of GCGR mRNA | 17q25.3 | |
| Copper | Approved Investigational | GCHFR | 2644 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of GCHFR mRNA | 15q15.1 | |
| Copper | Approved Investigational | GCLC | 2729 |
upregulated | Copper results in increased expression of GCLC mRNA | 6p12.1 | |
| Copper | Approved Investigational | GCLC | 2729 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GCLC mRNA | 6p12.1 | |
| Copper | Approved Investigational | GCLM | 2730 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of GCLM mRNA | 1p22.1 | |
| Copper | Approved Investigational | GCLM | 2730 |
upregulated | [Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA | 1p22.1 | |